Acotec Scientific Holdings (HKSE:06669) LT-Debt-to-Total-Asset: 0.08 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06669 Acotec Scientific Holdings Ltd HKSE:06669
76 GF Score
Price HK$6.26
GF Value HK$14.83
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Acotec Scientific Holdings LT-Debt-to-Total-Asset?

Acotec Scientific Holdings HKSE:06669 -1.73% 76 LT-Debt-to-Total-Asset is 0.08 as of Dec. 2025. GuruFocus rates HKSE:06669 with a GF Score™ of 76/100 and a GF Value™ of HK$14.83 (Significantly Undervalued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Acotec Scientific Holdings's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.08.

Acotec Scientific Holdings's long-term debt to total assets ratio declined from Dec. 2024 (0.10) to Dec. 2025 (0.08). It may suggest that Acotec Scientific Holdings is progressively becoming less dependent on debt to grow their business.

Acotec Scientific Holdings  (HKSE:06669) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Acotec Scientific Holdings LT-Debt-to-Total-Asset Related Terms

Acotec Scientific Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Acotec Scientific Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acotec Scientific Holdings LT-Debt-to-Total-Asset Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.01 0.03 0.12 0.10 0.08

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.10 0.09 0.08 0.08
HKSE:06669
76GF Score
Acotec Scientific Holdings Ltd HKSE:06669
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acotec Scientific Holdings LT-Debt-to-Total-Asset Calculation

Acotec Scientific Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=166.86/2063.734
=0.08

Acotec Scientific Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=166.86/2063.734
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.08 mean?
Acotec Scientific Holdings (HKSE:06669) has a LT-Debt-to-Total-Asset of 0.08 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Acotec Scientific Holdings and its competitors.
Is Acotec Scientific Holdings' LT-Debt-to-Total-Asset too high?
Acotec Scientific Holdings' current LT-Debt-to-Total-Asset is 0.08. Overall, Acotec Scientific Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' LT-Debt-to-Total-Asset compare to ABT and SYK?
Acotec Scientific Holdings' LT-Debt-to-Total-Asset of 0.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Acotec Scientific Holdings and its competitors. Acotec Scientific Holdings's current LT-Debt-to-Total-Asset is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Based on GuruFocus' analysis, Acotec Scientific Holdings (HKSE:06669) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.83, compared to a current price of HK$6.26 — trading 57.8% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.08. Acotec Scientific Holdings' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Acotec Scientific Holdings (HKSE:06669), the current LT-Debt-to-Total-Asset is 0.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acotec Scientific Holdings (HKSE:06669) Overvalued in 2026?

Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued. The current stock price of HK$6.26 is trading 57.8% below its estimated GF Value™ of HK$14.83. GuruFocus considers Acotec Scientific Holdings to be Significantly Undervalued.

Key valuation signals for HKSE:06669:

  • LT-Debt-to-Total-Asset: 0.08
  • GF Value™: HK$14.83 vs. price of HK$6.26 (57.8% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the HKSE:06669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acotec Scientific Holdings Business Description

Other Exchanges 7W3:Germany
Address 16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
76GF Score

Get the complete analysis for HKSE:06669

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.26
Price
HK$14.83
GF Value